Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|October 21, 2003
Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'IvoireChristiane A Adjé-Touré, Rachanee Cheingsong, J Gerardo Garcìa-Lerma, et al.
Frontiers in Immunology|November 20, 2012
Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell researchSilvia A Fuertes Marraco, Frédéric Grosjean, Anaïs Duval, et al.
Virology|December 9, 2000
Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaquesF Villinger, W M Switzer, B S Parekh, et al.
The Journal of Infectious Diseases|September 9, 2006
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challengesShambavi Subbarao, Ronald A Otten, Artur Ramos, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 7, 2010
Evolution of elastic x-ray scattering in laser-shocked warm dense lithiumN L Kugland, G Gregori, S Bandyopadhyay, et al.
United European Gastroenterology Journal|May 9, 2019
The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteriaXjnm Smeets, N Bouhouch, J Buxbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destructionXi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Plos Medicine|February 8, 2008
Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirJ Gerardo García-Lerma, Ron A Otten, Shoukat H Qari, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2024
Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approachAlexander Mustea, Damian J Ralser, Eva K Egger, et al.
British Journal of Cancer|June 5, 2015
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trialN Beije, J Kraan, W Taal, et al.
Pageof 16